According to a recent Schedule 13G form filed with the Securities and Exchange Commission, Paul Singer 's Elliott Associates L.P. owns 2.43 million shares in Fortress Biotech Inc. , which represent 5.18% of the company's outstanding common stock. This marks an increase of the fund's equity holding in Fortress Biotech of 1.98 million shares since its most recent 13F filing with the SEC for the reporting period of March 31. Elliott Management Corporation currently manages hedge funds Elliott Associates L.P. and Elliott International Limited, which together have more than $25 billion in assets under management as of December 31, 2014.